1 |
CROSBIE E J, KITSON S J, MCALPINE J N, et al. Endometrial cancer[J]. Lancet, 2022, 399(10333): 1412-1428.
|
2 |
周 琦, 吴小华, 刘继红, 等. 子宫内膜癌诊断与治疗指南(第四版)[J]. 中国实用妇科与产科杂志, 2018, 34(8): 880-886.
|
3 |
WANG H G, YANG Q J, LI J P, et al. microRNA-15a-5p inhibits endometrial carcinoma proliferation, invasion and migration via downregulation of VEGFA and inhibition of the Wnt/β-catenin signaling pathway[J]. Oncol Lett, 2021, 21(4): 310.
|
4 |
GENG A Z, LUO L, REN F Y, et al. miR-29a-3p inhibits endometrial cancer cell proliferation, migration and invasion by targeting VEGFA/CD C42/PAK1[J]. BMC Cancer, 2021, 21(1): 843.
|
5 |
SUN X M, HOU L T, QIU C P, et al. miR-501 promotes tumor proliferation and metastasis by targeting HOXD10 in endometrial cancer[J]. Cell Mol Biol Lett, 2021, 26(1): 20.
|
6 |
CORREIA DE SOUSA M, GJORGJIEVA M, DOLICKA D, et al. Deciphering miRNAs’ action through miRNA editing[J].Int J Mol Sci,2019,20(24): E6249.
|
7 |
GE S K, WANG D, KONG Q L, et al. Function of miR-152 as a tumor suppressor in human breast cancer by targeting PIK3CA[J]. Oncol Res, 2017, 25(8): 1363-1371.
|
8 |
LIU P H, WU L X, CHAND H, et al. Silencing of miR-152 contributes to DNMT1-mediated CpG methylation of the PTEN promoter in bladder cancer[J]. Life Sci, 2020, 261: 118311.
|
9 |
LI B, XIE Z S, LI B. miR-152 functions as a tumor suppressor in colorectal cancer by targeting PIK3R3[J]. Tumour Biol, 2016, 37(8): 10075-10084.
|
10 |
黄雨欣,雷 蕾,华克勤,辛卫娟.长链非编码RNA R P11-395G23.3在子宫内膜癌中的表达及其临床意义[J].同济大学学报(医学版),2021,42(3):321-326.
|
11 |
ZHAO YOU-BO, YUAN D Z, PAN J L, et al. Effect of progesterone-induced microRNA-152 on the proliferation of endometrial epithelial cells[J]. J Sichuan Univ Med Sci Ed, 2016, 47(2): 147-151.
|
12 |
BJORNSSON E, GUNNARSDOTTIR K, HALLDORSSON G H, et al. Lifelong reduction in LDL (low-density lipoprotein) cholesterol due to a gain-of-function mutation in LDLR[J]. Circ Genom Precis Med, 2021, 14(1): e003029.
|
13 |
FELDT M, MENARD J, ROSENDAHL A H, et al. The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression:a window-of-opportunity breast cancer trial[J]. Cancer Metab, 2020, 8(1): 25.
|
14 |
NIU X L, NONG S R, GONG J Y, et al. miR-194 promotes hepatocellular carcinoma through negative regulation of CADM1[J]. Int J Clin Exp Pathol, 2020, 13(7): 1518-1528.
|
15 |
LI X N, YANG H, YANG T. miR-122 inhibits hepatocarcinoma cell progression by targeting LMNB2 [J]. Oncol Res, 2020, 28(1): 41-49.
|
16 |
SARVIZADEH M, MALEKSHAHI Z V, RAZI E, et al. microRNA: a new player in response to therapy for colorectal cancer[J]. J Cell Physiol, 2019, 234(6): 8533-8540.
|
17 |
HUANG S L, TAN X H, HUANG Z C, et al. microRNA biomarkers in colorectal cancer liver metastasis[J]. J Cancer, 2018, 9(21): 3867-3873.
|
18 |
LI L W, XIAO H Q, MA R, et al. miR-152 is involved in the proliferation and metastasis of ovarian cancer through repression of ERBB3 [J]. Int J Mol Med, 2018, 41(3): 1529-1535.
|
19 |
XIANG Y, MA N, WANG D, et al. miR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine[J]. Oncogene, 2014, 33(3): 378-386.
|
20 |
ZHANG H Y, LU Y X, WANG S R, et al. microRNA-152 acts as a tumor suppressor microRNA by inhibiting krüppel-like factor 5 in human cervical cancer[J]. Oncol Res, 2019, 27(3): 335-340.
|
21 |
HUANG S D, LI X H, ZHU H T. microRNA-152 targets phosphatase and tensin homolog to inhibit apoptosis and promote cell migration of nasopharyngeal carcinoma cells[J]. Med Sci Monit,2016,22:4330-4337.
|
22 |
JEON H, BLACKLOW S C. Structure and physiologic function of the low-density lipoprotein receptor[J]. Annu Rev Biochem, 2005, 74: 535-562.
|
23 |
WILLNOW T E, NYKJAER A, HERZ J. Lipoprotein receptors: new roles for ancient proteins[J]. Nat Cell Biol, 1999, 1(6): E157-E162.
|
24 |
STOPSACK K H, GERKE T A, ANDRÉN O, et al. Cholesterol uptake and regulation in high-grade and lethal prostate cancers[J].Carcinogenesis,2017,38(8):806-811.
|
25 |
SUN Y, FENG Y, ZHANG G Q, et al. The endonuclease APE1 processes miR-92b formation, thereby regulating expression of the tumor suppressor LDLR in cervical cancer cells[J]. Ther Adv Med Oncol, 2019, 11: 1758835919855859.
|
26 |
CHEN Z Y, CHEN L, SUN B, et al. LDLR inhibition promotes hepatocellular carcinoma proliferation and metastasis by elevating intracellular cholesterol synthesis through the MEK/ERK signaling pathway[J]. Mol Metab, 2021, 51: 101230.
|